FB 918
Alternative Names: FB-918Latest Information Update: 03 Mar 2023
At a glance
- Originator Oneness Biotech
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Interleukin-33 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Asthma
Most Recent Events
- 11 Jan 2023 Preclinical trials in Asthma in Taiwan (Parenteral) (Oneness Biotech pipeline, January 2023)